Source:http://linkedlifedata.com/resource/pubmed/id/19013297
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2008-11-17
|
pubmed:abstractText |
Human serum paraoxonase 1 (PON1) is associated with high-density lipoprotein and inhibits oxidative modification of low-density lipoprotein in vitro. Therefore, PON1 is expected to protect against atherosclerosis in vivo. We and other investigators have shown that PON1 enzymatic activity is decreased in diabetic patients; however, an alteration in hepatic PON1 synthesis under hyperglycemic conditions remains unclear. We previously demonstrated that Sp1 is a positive regulator of PON1 transcription and that an interaction between Sp1 and protein kinase C (PKC) is a crucial mechanism for the effect of Sp1 on PON1 transcription in cultured HepG2 cells. Because several PKC isoforms are activated under hyperglycemic conditions, we examined the effect of d-glucose, which can activate the diacylglycerol-PKC pathway, on the transcription and expression of PON1. For a reporter gene assay, Huh7 human hepatocyte cell line incorporated with PON1 (-1232/-6)-luciferase expression vector was established using a cationic lipid method. d-Glucose dose dependently enhanced PON1 promoter activity. d-Glucose also enhanced both messenger RNA and protein expression of PON1. Increased PON1 expression was also detected in primary human hepatocytes treated with high d-glucose concentrations. Bisindolylmaleimide, a PKC inhibitor, significantly inhibited d-glucose-induced transactivation of PON1; and mithramycin, an inhibitor of Sp1, completely abrogated the transactivation. Our data suggest that high glucose concentrations transactivate the PON1 gene through Sp1 activation by PKC in cultured hepatocytes. Up-regulated hepatic PON1 expression under high glucose conditions may be a compensatory mechanism in diabetes in which antioxidant capacity, including PON1 enzymatic activity, is attenuated.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aryldialkylphosphatase,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/PON1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase C,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Sp1 Transcription Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1532-8600
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1725-32
|
pubmed:meshHeading |
pubmed-meshheading:19013297-Aryldialkylphosphatase,
pubmed-meshheading:19013297-Cells, Cultured,
pubmed-meshheading:19013297-Dose-Response Relationship, Drug,
pubmed-meshheading:19013297-Gene Expression Regulation, Enzymologic,
pubmed-meshheading:19013297-Glucose,
pubmed-meshheading:19013297-Hepatocytes,
pubmed-meshheading:19013297-Humans,
pubmed-meshheading:19013297-Promoter Regions, Genetic,
pubmed-meshheading:19013297-Protein Kinase C,
pubmed-meshheading:19013297-RNA, Messenger,
pubmed-meshheading:19013297-Sp1 Transcription Factor,
pubmed-meshheading:19013297-Transcriptional Activation,
pubmed-meshheading:19013297-Transfection
|
pubmed:year |
2008
|
pubmed:articleTitle |
High glucose induces transactivation of the human paraoxonase 1 gene in hepatocytes.
|
pubmed:affiliation |
Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Nankoku, Kochi 783-8505, Japan.
|
pubmed:publicationType |
Journal Article
|